在患有原发性高凝血性障碍的患者中进行自主乳房重建
Nicholas R Fadell1, Kevin He1, Adam Boukind1
1Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
概括
自主乳房重建对于高凝血患者是安全的. 谨慎的抗凝管理是最大限度地降低血栓形成风险,并确保在自由翻盖乳房重建中取得成功的结果的关键.
科学领域:
- 整形外科 整形外科 整形外科
- 血管外科 血管外科
- 血液学 血液学 血液学
背景情况:
- 自主乳房重建越来越受欢迎.
- 患有高凝血性疾病的患者面临高血栓风险.
- 这些风险给重建性手术带来了挑战.
研究的目的:
- 评估自主乳房重建在患有高凝血性疾病的患者的安全性和有效性.
- 评估抗凝血疗法对片存活率的影响.
主要方法:
- 对13名患者进行23次自由片乳房重建的回顾性审查.
- 分析了1998年至2023年间使用的各种抗凝策略.
主要成果:
- 观察到4%的低折叠板损失率.
- 术前和术后的抗凝药可以减少血栓性并发症.
结论:
- 自主乳房重建是高凝血患者的可靠选择.
- 精心的抗凝管理对于成功的结果至关重要.
更多相关视频
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
2.3K
09:09A Modified Heterotopic Swine Hind Limb Transplant Model for Translational Vascularized Composite Allotransplantation VCA Research
Published on: October 14, 2013
12.4K
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
536
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
536
01:24Disorders of Hemostasis
638
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
638